Greg Wang publication in Blood “PHF19 promotes multiple myeloma tumorigenicity through PRC2 activation”
August 6, 2019
The LLS grant will enable Wang lab to carry out unbiased oncogene target screening and shift towards new therapies of hematological malignancies.
In the journal Molecular Cell, researchers led by G. Greg Wang, PhD, Associate Professor of Biochemistry and Biophysics, and H. Shelton Earp, MD, describe the role of a protein variant called androgen receptor variant 7 (AR-V7), which is an alternative form of the androgen receptor that plays a key role in prostate cancer development and treatment.
Congratulations to Greg Wang and Qi Zhang, associate professors of biochemistry and biophysics who received tenure as a UNC faculty effective June 1, 2018.
The Leukemia & Lymphoma Society has awarded Biochemistry and Biophysics Associate Professor G. Greg Wang, PhD, a five year, $550,000 Career Development Program Scholar Grant to support his research to decipher and target acute myeloid leukemia cell dependency and epigenetic mutations.
In the journal Nature, Greg Wang, PhD, assistant professor of Biochemistry and Biophysics and Cell biology Program, and colleagues reported findings about the structure and function of the DNMT3A enzyme complex, which helps control gene expression.
The American Cancer Society awards Greg Wang, Assistant Professor of Biochemistry & Biophysics, a research scholar grant to study the role of PRC2 dysregulation in cancer.